Skip to main content

Table 8 Difference in means between treatment and control groups for HDL at final follow-up

From: Screening for thyroid dysfunction and treatment of screen-detected thyroid dysfunction in asymptomatic, community-dwelling adults: a systematic review

Author

Sample size (treatment group vs. control group)

Difference

95% CI

Cabral et al. [57]

32 (14 vs. 18)

0.26 mmol/L*

− 0.17 to 0.70

Caraccio et al. [58]

49 (24 vs. 25)

− 0.10 mmol/L*

− 0.27 to 0.07

Duman et al. [60]

39 (20 vs. 19)

0.004 mmol/L*

− 0.45 to 0.44

Iqbal et al. [62]

64 (32 vs. 32)

0.00 mmol/L*

− 0.22 to 0.22

Liu et al. [64]

119 (60 vs. 59)

0.03 mmol/L**

− 0.03 to 0.09

Mikhail et al. [66]

120 (60 vs. 60)

0.09 mmol/L*

− 0.01 to 0.20

Monzani et al. [68]

45 (23 vs. 22)

− 0.17 mmol/L*

− 0.49 to 0.14

Nagasaki et al. [69]

95 (48 vs. 47)

0.02 mmol/L**

− 0.12 to 0.16

Teixeira et al. [74, 75]

26 (11 vs. 15)

0.35 mmol/L*

− 0.29 to 0.99

  1. *Value is the difference in mean scores at final follow-up between treatment and control groups
  2. **Value is the difference in mean variation scores from baseline to follow-up between treatment and control group